Commenting on the quarter, Stephen Hagge, President and CEO, said, “We are pleased to report record third quarter sales in spite of some challenges in the markets we are serving. Our Pharma segment had a good quarter driven primarily by increased demand from the consumer health care and injection markets. Our Beauty + Home segment’s sales also grew, even with decreased demand in the U.S. Weaker volumes in the beverage market and a decrease in custom tooling sales were offset by increased demand from the food market in our Food + Beverage segment.”

Hagge continued, “We were able to generate healthy earnings, even though we faced challenges including the ongoing weak volumes in the U.S., increases in the cost of plastic resin, and negative Latin American currency transaction effects.”

In the quarter, AptarGroup recognized charges related to its European restructuring plan and this had a negative effect on earnings per share of approximately $0.03. AptarGroup’s previous earnings per share guidance for the third quarter did not include any impact from this plan. Third quarter earnings per share, excluding the charges related to this plan, were $0.70. Prior year comparable earnings per share were $0.66 when the negative impact from non-recurring purchase accounting effects relating to the Stelmi acquisition were excluded (approximately $0.04 per share).

YEAR-TO-DATE RESULTS

For the nine months ended September 30, 2013, reported sales increased 7% to $1.88 billion from $1.76 billion a year ago. Aptar Stelmi contributed approximately $74 million or 4% to the year-to-date sales growth while changes in currency exchange rates added an additional 1%.
Nine Months Year-to-Date Segment Sales Analysis

(Change Over Prior Year)
 
 

Beauty +Home
  Pharma  

Food +Beverage
 

TotalAptarGroup
Product Sales (including tooling) 1%   3%   7%   2%
Currency Effects 2% 1% 1%
Acquisitions     17%       4%
Total Reported Growth 1%   22%   8%   7%

Hagge commented on the year-to-date results, “The diversity of Aptar’s business continues to be a long-term stabilizing factor. Even with challenges coming from different areas of our business, each segment grew core sales over the prior year. We continue to focus on the markets we serve and consumer application fields that will lead to growth opportunities.”

If you liked this article you might like

AptarGroup (ATR) Reaches New Lifetime High Today

3 Stocks With Upcoming Ex-Dividend Dates: PHF, DBD, ATR

New Lifetime High For AptarGroup (ATR)

Where to Put Your Money Post-Brexit: What Wall Street's Saying

Jim Cramer's 'Mad Money' Recap: These Stocks Have Staying Power